Healthcare Sector
Biotechnology & Drugs Industry 
|
|
|
Data by Company within Biotechnology & Drugs Industry
|
|
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
Company |
(Millions) |
(Millions) |
(Millions) |
Number |
Abbvie Inc. |
$ 128,663 |
$ 32,624 |
$ 4,118 |
26,000 |
Arca Biopharma, Inc. |
$ 8 |
- |
$ -6 |
- |
American Bio Medica Corp |
$ 2 |
$ 4 |
$ -1 |
- |
Acorda Therapeutics Inc |
$ 84 |
$ 223 |
$ -258 |
- |
Aclaris Therapeutics, Inc. |
$ 75 |
$ 16 |
$ -181 |
- |
Actavis Plc |
$ 4,319 |
$ 10,573 |
$ -751 |
19,200 |
Ocata Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Adaptimmune Therapeutics Plc |
$ 768 |
$ 51 |
$ -137 |
- |
Fennec Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
Adma Biologics, Inc. |
$ 247 |
$ 21 |
$ -56 |
- |
Adverum Biotechnologies, Inc. |
$ 690 |
$ 2 |
$ -66 |
- |
Aerie Pharmaceuticals, Inc. |
$ 973 |
$ 48 |
$ -232 |
- |
Agenus Inc |
$ 534 |
$ 122 |
$ -132 |
- |
Allergan plc |
$ 61,218 |
$ 15,818 |
$ -9,244 |
10,500 |
Applied Genetic Technologies Corp |
$ 49 |
$ 44 |
$ -5 |
- |
Akers Biosciences, Inc. |
$ 40 |
$ 2 |
$ -6 |
- |
Alder Biopharmaceuticals Inc |
$ 1,579 |
- |
$ -317 |
- |
Alliance Bioenergy Plus, Inc. |
$ 8 |
- |
$ -11 |
- |
Amarillo Biosciences Inc |
$ 12 |
$ 0 |
$ -2 |
- |
Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
Amgen Inc. |
$ 140,874 |
$ 32,341 |
$ 8,067 |
17,900 |
Albany Molecular Research Inc |
$ 928 |
$ 681 |
$ -60 |
- |
Amyris, Inc. |
$ 335 |
$ 115 |
$ -256 |
440 |
Alpha Network Alliance Ventures Inc. |
$ 13 |
$ 0 |
$ -1 |
7 |
Aeolus Pharmaceuticals, Inc. |
$ 0 |
$ 1 |
$ -4 |
- |
Armata Pharmaceuticals, Inc. |
$ 3 |
$ 0 |
$ -16 |
- |
Aptevo Therapeutics Inc. |
$ 28 |
$ 30 |
$ -46 |
- |
Ariad Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
Arno Therapeutics, Inc |
- |
- |
$ 0 |
- |
Assembly Biosciences, inc. |
$ 459 |
$ 15 |
$ -97 |
- |
Asterias Biotherapeutics, Inc. |
$ 51 |
$ 3 |
$ -24 |
- |
Atara Biotherapeutics, Inc. |
$ 729 |
- |
$ -279 |
- |
Kubota Pharmaceutical Holdings Co Ltd |
- |
- |
$ 0 |
- |
Anavex Life Sciences Corp. |
$ 117 |
$ 1 |
$ -28 |
- |
Axim Biotechnologies, Inc. |
$ 26 |
$ 1 |
$ -6 |
- |
Axovant Gene Therapies Ltd. |
$ 28 |
- |
$ -85 |
- |
Aytu Bioscience, Inc |
$ 11 |
$ 7 |
$ -29 |
- |
Azurrx Biopharma, Inc. |
$ 18 |
- |
$ -18 |
- |
Brainstorm Cell Therapeutics Inc. |
$ 87 |
- |
$ -21 |
- |
Biocryst Pharmaceuticals Inc |
$ 305 |
$ 12 |
$ -134 |
- |
Beesfree, Inc. |
- |
- |
$ 0 |
- |
Bg Medicine, Inc. |
- |
- |
$ 0 |
- |
U.s. Stem Cell, Inc. |
- |
$ 4 |
$ -4 |
- |
Premier Biomedical Inc |
$ 0 |
$ 0 |
$ -1 |
- |
Biogen Inc. |
$ 53,829 |
$ 14,182 |
$ 5,428 |
7,550 |
Immucor Inc |
- |
- |
$ 0 |
- |
Bluebird Bio, Inc. |
$ 4,809 |
$ 54 |
$ -715 |
- |
Mj Biotech, Inc. |
- |
- |
$ -1 |
2 |
Bionovo Inc |
- |
- |
$ 0 |
- |
Audentes Therapeutics, inc. |
$ 2,707 |
- |
$ -175 |
- |
Bohai Pharmaceuticals Group, Inc. |
$ 7 |
$ 165 |
$ 22 |
- |
Biopharmx Corporation |
$ 6 |
$ 0 |
$ -13 |
- |
Bespoke Tricycles Inc |
$ 2 |
$ 1 |
$ -9 |
- |
Biorestorative Therapies, Inc. |
$ 1 |
$ 0 |
$ -17 |
- |
Boston Therapeutics, Inc. |
$ 1 |
$ 0 |
$ -3 |
- |
Lineage Cell Therapeutics, Inc. |
$ 138 |
$ 3 |
$ -52 |
- |
Burzynski Research Institute Inc |
$ 2 |
- |
$ -2 |
- |
Cadence Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
General Cannabis Corp |
$ 27 |
$ 4 |
$ -11 |
- |
Capricor Therapeutics, Inc. |
$ 5 |
$ 1 |
$ -9 |
- |
Capstone Therapeutics Corp. |
$ 1 |
- |
$ -4 |
- |
Casi Pharmaceuticals, Inc. |
$ 302 |
$ 3 |
$ -41 |
- |
Catalyst Biosciences, Inc. |
$ 61 |
$ 1 |
$ -52 |
- |
Cellular Biomedicine Group, Inc. |
$ 319 |
$ 0 |
$ -46 |
- |
China Botanic Pharmaceutical |
- |
- |
$ 0 |
- |
China Biologic Products Holdings, Inc. |
$ 4,244 |
$ 467 |
$ 148 |
- |
Cellcyte Genetics Corp. |
- |
- |
$ 0 |
- |
Cidara Therapeutics, Inc. |
$ 103 |
- |
$ -40 |
- |
Chromadex Corp. |
$ 230 |
$ 42 |
$ -32 |
- |
Cardax, Inc. |
$ 8 |
$ 1 |
$ -5 |
- |
Cen Biotech Inc |
- |
- |
$ -8 |
- |
Cerecor Inc. |
$ 240 |
$ 20 |
$ -25 |
- |
Compugen Ltd |
$ 352 |
$ 18 |
$ -23 |
- |
Coherus Biosciences, Inc. |
$ 1,406 |
$ 178 |
$ 3 |
- |
Chelsea Therapeutics International, Ltd. |
- |
- |
$ 0 |
- |
China Kangtai Cactus Bio-tech, Inc. |
- |
- |
$ 0 |
- |
Celldex Therapeutics, Inc. |
$ 34 |
$ 4 |
$ -50 |
- |
Cell Medx Corp. |
$ 8 |
$ 0 |
$ -1 |
4 |
United Cannabis Corp |
$ 14 |
$ 16 |
$ -21 |
- |
Cannabics Pharmaceuticals Inc. |
- |
$ 0 |
$ 1 |
- |
Compass Biotechnologies Inc. |
- |
- |
$ 0 |
- |
Cohbar, Inc. |
- |
- |
$ -14 |
- |
Cocrystal Pharma, Inc. |
$ 17 |
- |
$ -45 |
- |
Core Lithium Corp. |
$ 52 |
- |
$ -4 |
- |
Cannapharmarx, Inc. |
$ 53 |
- |
$ -13 |
- |
Curis Inc |
$ 52 |
$ 10 |
$ -30 |
- |
Crispr Therapeutics Ag |
$ 3,781 |
$ 213 |
$ -11 |
- |
American Cryostem Corp |
$ 17 |
$ 0 |
$ -1 |
- |
Champions Oncology, Inc. |
$ 77 |
$ 28 |
$ -1 |
- |
Cyclo Therapeutics, Inc. |
$ 31 |
$ 2 |
$ -6 |
6 |
Cytomx Therapeutics, Inc. |
$ 301 |
$ 60 |
$ -102 |
- |
Citius Pharmaceuticals, Inc. |
$ 11 |
- |
$ -15 |
1 |
Neuralstem, Inc. |
$ 5 |
$ 0 |
$ -7 |
- |
Cel Sci Corp |
$ 255 |
- |
$ -32 |
- |
Cv Sciences, Inc. |
- |
$ 22 |
$ -5 |
- |
Cyanotech Corp |
$ 13 |
$ 32 |
$ -1 |
124 |
Cytodyn Inc. |
$ 106 |
- |
$ -58 |
- |
Cytrx Corp |
$ 8 |
- |
$ -7 |
- |
Enochian Biosciences Inc |
$ 280 |
- |
$ -43 |
- |
Diadexus, Inc. |
- |
- |
$ 0 |
- |
Diffusion Pharmaceuticals Inc. |
$ 3 |
- |
$ -14 |
- |
Delmar Pharmaceuticals, Inc. |
$ 5 |
- |
$ 21 |
- |
Dimension Therapeutics, Inc. |
$ 149 |
$ 17 |
$ -56 |
- |
Dna Testing Centers Corp |
- |
$ 0 |
$ 0 |
- |
Dendreon Corp |
- |
- |
$ 0 |
- |
Noho, Inc. |
- |
- |
$ 0 |
- |
Ds Healthcare Group, Inc. |
$ 0 |
$ 12 |
$ -6 |
105 |
Emergent Biosolutions Inc. |
$ 2,746 |
$ 878 |
$ -18 |
- |
Pds Biotechnology Corp |
$ 3 |
- |
$ -6 |
- |
Eiger Biopharmaceuticals, Inc. |
$ 312 |
- |
$ -70 |
- |
Empowered Products, Inc. |
- |
- |
$ 0 |
- |
Endonovo Therapeutics, Inc. |
$ 2 |
$ 0 |
$ -10 |
- |
Entremed Inc |
- |
- |
$ 0 |
- |
Entest Group, Inc. |
$ 2 |
- |
$ -1 |
- |
Enumeral Biomedical Holdings, Inc. |
$ 0 |
$ 2 |
$ -13 |
- |
Enzon Pharmaceuticals, Inc. |
$ 10 |
$ 7 |
$ 6 |
- |
Enzymotec Ltd. |
- |
- |
$ 0 |
124 |
Entia Biosciences, Inc. |
$ 0 |
$ 0 |
$ -1 |
- |
Eastgate Biotech Corp |
- |
$ 0 |
$ -3 |
- |
Fate Therapeutics Inc |
$ 1,250 |
$ 7 |
$ -83 |
- |
Fulgent Genetics, Inc. |
$ 239 |
$ 30 |
$ -2 |
- |
Foamix Pharmaceuticals Ltd. |
$ 155 |
$ 3 |
$ 71 |
68 |
Global Future City Holding Inc. |
$ 3 |
$ 3 |
$ -5 |
- |
Sellas Life Sciences Group, Inc. |
$ 1 |
$ 2 |
$ -34 |
- |
Gentium S.p.a. |
- |
- |
$ 0 |
- |
Synageva Biopharma Corp |
- |
- |
$ 0 |
- |
Gilead Sciences, Inc. |
$ 85,877 |
$ 22,365 |
$ 2,678 |
7,000 |
Glucose Health, Inc. |
$ 0 |
- |
$ 0 |
1 |
Genocea Biosciences, Inc. |
$ 61 |
- |
$ -20 |
- |
Aevi Genomic Medicine, Inc. |
$ 10 |
- |
$ -18 |
- |
Green Planet Bio Engineering Co. Ltd. |
$ 1 |
- |
$ 0 |
- |
Optec International, Inc. |
$ 59 |
$ 0 |
$ -1 |
- |
Guided Therapeutics Inc |
$ 1 |
$ 0 |
$ 4 |
- |
Genethera Inc |
$ 0 |
- |
$ -1 |
- |
Gtx Corp |
$ 0 |
$ 1 |
$ -1 |
- |
Green Vision Biotechnology Corp. |
- |
$ 0 |
$ -4 |
- |
Halozyme Therapeutics, Inc. |
$ 2,739 |
$ 203 |
$ -40 |
- |
Hubei Minkang Pharmaceutical Ltd. |
- |
- |
$ 0 |
- |
Health Discovery Corp |
- |
- |
$ 0 |
- |
Aim Immunotech Inc. |
$ 5 |
$ 0 |
$ -10 |
- |
Inhibitor Therapeutics, Inc. |
$ 32 |
- |
$ -3 |
- |
Hyperion Therapeutics Inc |
- |
- |
$ 0 |
- |
Heska Corp |
$ 714 |
$ 124 |
$ 1 |
- |
Hst Global, Inc. |
$ 0 |
- |
$ 0 |
- |
Idera Pharmaceuticals, Inc. |
$ 47 |
$ 1 |
$ -45 |
- |
Teligent, Inc. |
$ 1,449 |
$ 52 |
$ 18 |
- |
Intelgenx Technologies Corp. |
$ 50 |
$ 2 |
$ -11 |
- |
Intellect Neurosciences, Inc. |
$ 0 |
- |
$ -15 |
- |
Conversion Labs, Inc. |
$ 11 |
$ 4 |
$ -2 |
11 |
Epicure Charcoal, Inc. |
$ 0 |
- |
$ 0 |
- |
Immunomedics, Inc. |
$ 3,980 |
$ 2 |
$ -429 |
- |
Immune Therapeutics, Inc. |
$ 0 |
- |
$ -3 |
- |
Integrated Biopharma Inc |
$ 8 |
$ 51 |
$ 2 |
- |
Infinity Pharmaceuticals, Inc. |
$ 67 |
$ 3 |
$ -44 |
23 |
Artemis Therapeutics, Inc. |
- |
- |
$ 0 |
1 |
Innovus Pharmaceuticals, Inc. |
$ 2 |
$ 23 |
$ -8 |
- |
Renovacare, Inc. |
- |
- |
$ -3 |
- |
Jounce Therapeutics, Inc. |
$ 312 |
$ 168 |
$ 235 |
- |
Juno Therapeutics, Inc. |
$ 9,815 |
$ 112 |
$ -437 |
- |
Cadus Corp |
$ 42 |
- |
$ -3 |
- |
Kite Pharma, Inc. |
$ 10,187 |
$ 32 |
$ -359 |
- |
Lescarden Inc |
- |
- |
$ 0 |
- |
Atyr Pharma Inc |
$ 17 |
- |
$ -24 |
- |
Lixte Biotechnology Holdings, Inc. |
$ 60 |
- |
$ -2 |
- |
La Jolla Pharmaceutical Co |
$ 88 |
$ 20 |
$ -137 |
- |
Opiant Pharmaceuticals, Inc. |
- |
$ 38 |
$ 1 |
- |
Lazuriton Nano Biotechnology (u.s.a.) Inc. |
- |
- |
$ 0 |
- |
Apollo Endosurgery, Inc. |
- |
$ 64 |
$ -28 |
- |
Mateon Therapeutics Inc |
$ 9 |
- |
$ 0 |
- |
Mabvax Therapeutics Holdings, Inc. |
$ 2 |
- |
$ -20 |
- |
Multicell Technologies, Inc. |
$ 0 |
$ 0 |
$ -1 |
- |
Mctc Holdings, Inc. |
$ 72 |
- |
$ 0 |
- |
Manhattan Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
Micromet, Inc. |
- |
- |
$ 0 |
- |
Mj Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
Cure Pharmaceutical Holding Corp. |
- |
$ 1 |
$ -31 |
1 |
Momenta Pharmaceuticals, inc. |
$ 1,551 |
$ 59 |
$ -212 |
- |
Mount Tam Biotechnologies, Inc. |
$ 1 |
- |
$ -1 |
- |
Myriad Genetics Inc |
$ 1,562 |
$ 773 |
$ 131 |
- |
Mymetics Corp |
- |
$ 1 |
$ -5 |
- |
Myokardia Inc |
$ 3,035 |
$ 22 |
$ -111 |
- |
Myrexis, Inc. |
- |
- |
$ 0 |
- |
Navidea Biopharmaceuticals, Inc. |
$ 19 |
$ 1 |
$ -11 |
- |
Nascent Biotech Inc. |
$ 5 |
- |
$ -1 |
- |
Neurocrine Biosciences Inc |
$ 10,734 |
$ 277 |
$ 18 |
- |
Caladrius Biosciences, Inc. |
- |
$ 36 |
$ -18 |
- |
Northsight Capital, Inc. |
- |
$ 0 |
$ -2 |
- |
Neogen Corp |
$ 3,540 |
$ 416 |
$ 60 |
- |
Nexus Biopharma Inc |
- |
- |
$ 0 |
- |
Nantkwest, Inc. |
$ 189 |
$ 0 |
$ -67 |
- |
Neoleukin Therapeutics, Inc. |
$ 203 |
- |
$ -66 |
- |
Biovie Inc. |
- |
- |
$ -6 |
- |
Nutra Pharma Corp. |
$ 1 |
$ 0 |
$ -7 |
- |
Nanostring Technologies Inc |
$ 904 |
$ 119 |
$ -86 |
- |
Intellia Therapeutics, Inc. |
$ 801 |
$ 40 |
$ -90 |
- |
Nbty Inc |
- |
- |
$ 0 |
- |
Nugene International, Inc. |
- |
- |
$ 0 |
8 |
Nutrastar International Inc. |
- |
- |
$ 0 |
- |
Novavax Inc |
$ 99 |
$ 16 |
$ -150 |
- |
N-viro International Corporation |
- |
- |
$ 0 |
- |
Obalon Therapeutics Inc |
$ 11 |
$ 5 |
$ -28 |
- |
Oncbiomune Pharmaceuticals, Inc |
$ 0 |
$ 0 |
$ -5 |
- |
Oncocyte Corp |
$ 101 |
- |
$ -19 |
- |
Spark Therapeutics, Inc. |
$ 4,298 |
$ 70 |
$ -33 |
- |
Organovo Holdings, Inc. |
$ 65 |
$ 3 |
$ -26 |
- |
Orgenesis Inc. |
$ 43 |
$ 29 |
$ 22 |
- |
Osiris Therapeutics, Inc. |
$ 656 |
$ 113 |
$ 5 |
- |
Oncovista Innovative Therapies, Inc |
- |
- |
$ 0 |
- |
Oxford Immunotec Global Plc |
$ 465 |
$ 49 |
$ 141 |
- |
Mateon Therapeutics Inc |
- |
- |
$ -3 |
- |
Gt Biopharma, Inc. |
$ 4 |
- |
$ -41 |
- |
Prolor Biotech, Inc. |
- |
- |
$ 0 |
- |
Procyon Corp |
$ 2 |
$ 4 |
$ 0 |
- |
Pdl Biopharma, Inc. |
$ 393 |
$ 135 |
$ 19 |
- |
Quint Media Inc. |
- |
- |
$ 0 |
- |
Petvivo Holdings, Inc. |
$ 11 |
$ 0 |
$ -3 |
4 |
Protokinetix, Inc. |
$ 29 |
- |
$ -2 |
- |
Pulse Biosciences, Inc. |
$ 311 |
$ 1 |
$ -42 |
- |
Protalix Biotherapeutics, Inc. |
$ 46 |
$ 14 |
$ -9 |
- |
Pharmacyte Biotech, Inc. |
- |
- |
$ -4 |
- |
Proteon Therapeutics Inc |
$ 6 |
- |
$ -19 |
- |
Pluristem Therapeutics Inc |
$ 53 |
$ 1 |
$ -34 |
- |
Proteo Inc |
$ 1 |
$ 0 |
$ 0 |
- |
Protagonist Therapeutics, Inc. |
$ 192 |
$ 14 |
$ -77 |
- |
Proteostasis Therapeutics, Inc. |
$ 218 |
$ 6 |
$ -66 |
- |
Pulmatrix, Inc. |
$ 18 |
- |
$ -21 |
- |
Pivot Pharmaceuticals Inc. |
$ 15 |
- |
$ -7 |
- |
Q Biomed Inc. |
$ 21 |
$ 0 |
$ -10 |
8 |
Quidel Corp |
$ 6,079 |
$ 515 |
$ 75 |
- |
Qiagen Nv |
$ 9,612 |
$ 1,502 |
$ 190 |
- |
Quest Patent Research Corp |
$ 4 |
$ 2 |
$ -2 |
2 |
Quotient Ltd |
$ 576 |
$ 31 |
$ -103 |
- |
Quint Media Inc. |
- |
- |
$ 0 |
- |
Rich Pharmaceuticals, Inc. |
$ 0 |
- |
$ 0 |
- |
Regenocell Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Receptos, Inc. |
- |
- |
$ 0 |
- |
Ridgefield Acquisition Corp |
$ 3 |
- |
$ 0 |
- |
Restorgenex Corp |
- |
- |
$ 0 |
- |
Regen Biopharma Inc |
$ 0 |
- |
$ -5 |
- |
Regado Biosciences Inc |
- |
- |
$ 0 |
- |
Repligen Corp |
$ 4,703 |
$ 250 |
$ 23 |
- |
Regenxbio Inc. |
$ 1,484 |
$ 94 |
$ -17 |
- |
Regenerx Biopharmaceuticals Inc |
$ 21 |
$ 0 |
$ -1 |
- |
Relmada Therapeutics, Inc. |
$ 332 |
- |
$ -18 |
- |
Repros Therapeutics Inc. |
$ 25 |
$ 0 |
$ -14 |
- |
Respirerx Pharmaceuticals Inc. |
$ 1 |
- |
$ -2 |
- |
Aytu Bioscience, Inc. |
- |
- |
$ 0 |
- |
Ruthigen, Inc. |
- |
- |
$ 0 |
- |
Radient Pharmaceuticals Corp |
- |
- |
$ 0 |
- |
Strongbridge Biopharma Plc |
$ 98 |
$ 21 |
$ 44 |
- |
Sangui Biotech International Inc |
$ 4 |
$ 0 |
$ 0 |
- |
Seattle Genetics Inc |
$ 18,717 |
$ 801 |
$ -304 |
- |
Sangamo Therapeutics, Inc |
$ 1,000 |
$ 74 |
$ -119 |
- |
Shengtai Pharmaceutical, Inc. |
- |
- |
$ 0 |
- |
Skinovation Pharmaceutical Inc |
- |
- |
$ 0 |
- |
Skinvisible, Inc. |
$ 0 |
$ 0 |
$ -2 |
- |
Sun Biopharma, Inc. |
$ 26 |
- |
$ -6 |
- |
Syndax Pharmaceuticals Inc |
$ 277 |
$ 2 |
$ -64 |
- |
Soligenix, Inc. |
$ 25 |
$ 5 |
$ -10 |
- |
Senesco Technologies Inc |
- |
- |
$ 0 |
- |
Senesco Technologies Inc |
- |
- |
$ -8 |
- |
Spotlight Innovation Inc. |
$ 0 |
$ 0 |
$ -5 |
2 |
Sunwin Stevia International, Inc. |
$ 8 |
$ 27 |
$ -7 |
- |
Intellicell Biosciences, Inc. |
- |
- |
$ 0 |
- |
Savient Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
Tobira Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Tracon Pharmaceuticals, Inc. |
$ 84 |
$ 11 |
$ -26 |
- |
Bio-techne Corp |
$ 8,443 |
$ 714 |
$ 96 |
- |
Telik Inc |
- |
- |
$ 0 |
- |
Mabvax Therapeutics Holdings, Inc. |
- |
- |
$ 0 |
- |
Tongli Pharmaceuticals (usa), Inc. |
$ 0 |
- |
$ 0 |
- |
Tg Therapeutics, Inc. |
$ 802 |
$ 0 |
$ -114 |
- |
Tg Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Twinlab Consolidated Holdings, Inc. |
$ 65 |
$ 75 |
$ -18 |
- |
True Nature Holding, Inc. |
$ 2 |
- |
$ -3 |
1 |
Targeted Medical Pharma, Inc. |
- |
- |
$ 0 |
- |
Targacept Inc |
- |
- |
$ 0 |
- |
Trovagene, Inc. |
$ 8 |
$ 0 |
$ -17 |
- |
Therapeutic Solutions International, Inc. |
$ 2 |
$ 0 |
$ -2 |
- |
Trius Therapeutics Inc |
- |
- |
$ 0 |
- |
Taxus Pharmaceuticals Holdings, Inc. |
- |
- |
$ 0 |
- |
Uluru Inc. |
$ 5 |
$ 1 |
$ -2 |
- |
United Bancshares Inc |
- |
- |
$ 0 |
- |
Vitality Biopharma, Inc. |
$ 3 |
$ 0 |
$ -21 |
- |
Vericel Corp |
$ 784 |
$ 102 |
$ -18 |
- |
Meridian Bioscience Inc |
$ 396 |
$ 203 |
$ 26 |
- |
Volitionrx Ltd |
$ 185 |
- |
$ -18 |
- |
Viropharma Inc |
- |
- |
$ 0 |
- |
Vermillion, Inc. |
$ 73 |
$ 4 |
$ -15 |
- |
Vistagen Therapeutics, Inc. |
$ 23 |
- |
$ -26 |
- |
Ventrus Biosciences Inc |
- |
- |
$ 0 |
- |
Voyager Therapeutics, Inc. |
$ 510 |
$ 48 |
$ -59 |
- |
Warner Chilcott Plc |
- |
- |
$ 0 |
- |
Windtree Therapeutics Inc |
$ 116 |
$ 1 |
$ -42 |
- |
Weikang Bio-technology Group Co., Inc. |
- |
- |
$ 0 |
- |
Wave Life Sciences Ltd. |
$ 1,224 |
$ 19 |
$ -162 |
- |
Xenetic Biosciences, Inc. |
$ 5 |
- |
$ -13 |
- |
Acceleron Pharma Inc |
$ 2,597 |
$ 38 |
$ -120 |
- |
Eidos Therapeutics, Inc. |
$ 2,474 |
- |
$ 2 |
- |
Xstelos Holdings, Inc. |
- |
- |
$ 0 |
- |
Vilacto Bio Inc. |
- |
$ 0 |
$ -1 |
1 |
Iovance Biotherapeutics, inc. |
$ 3,117 |
- |
$ -167 |
- |
G1 Therapeutics, Inc. |
$ 866 |
- |
$ -111 |
- |
Aerpio Pharmaceuticals, Inc. |
$ 23 |
- |
$ -27 |
- |
Sienna Biopharmaceuticals, Inc. |
$ 4 |
- |
$ -48 |
- |
Qrons Inc. |
$ 14 |
- |
$ -3 |
- |
Krystal Biotech, Inc. |
$ 1,071 |
- |
$ -16 |
- |
Allena Pharmaceuticals, Inc. |
$ 45 |
- |
$ -46 |
- |
Urogen Pharma Ltd. |
$ 705 |
$ 8 |
$ -140 |
- |
Eloxx Pharmaceuticals, Inc. |
$ 280 |
- |
$ -53 |
- |
Cv Sciences, Inc. |
$ 111 |
$ 59 |
$ -7 |
- |
Eyenovia, Inc. |
$ 56 |
- |
$ -22 |
- |
Nightstar Therapeutics Plc |
$ 840 |
- |
$ -53 |
- |
Zai Lab Ltd |
$ 2,207 |
$ 0 |
$ -139 |
- |
Zymeworks Inc. |
$ 1,835 |
$ 57 |
$ -64 |
- |
Scpharmaceuticals Inc. |
$ 76 |
- |
$ -27 |
- |
Cannapowder, Inc. |
$ 12 |
- |
$ -2 |
- |
Arcus Biosciences, Inc. |
$ 387 |
$ 10 |
$ -79 |
- |
Clementia Pharmaceuticals Inc. |
$ 836 |
- |
$ 0 |
- |
Oncternal Therapeutics, Inc. |
$ 71 |
- |
$ -43 |
- |
Solid Biosciences Inc. |
$ 179 |
- |
$ -107 |
- |
Denali Therapeutics Inc. |
$ 1,735 |
$ 148 |
$ 39 |
- |
Cue Biopharma, Inc. |
- |
$ 2 |
$ -39 |
- |
Homology Medicines, Inc. |
$ 875 |
$ 2 |
$ -99 |
- |
Unum Therapeutics Inc. |
$ 16 |
$ 11 |
$ -43 |
- |
Nymox Pharmaceutical Corporation |
$ 140 |
$ 0 |
$ -21 |
- |
Armo Biosciences, Inc. |
- |
- |
$ 0 |
- |
Surface Oncology, Inc. |
$ 51 |
$ 25 |
$ -17 |
- |
Evelo Biosciences, Inc. |
$ 141 |
- |
$ -78 |
- |
Unity Biotechnology, Inc. |
$ 332 |
- |
$ -86 |
- |
Avricore Health Inc. |
- |
- |
$ 0 |
- |
Kazia Therapeutics Ltd |
$ 3 |
$ 1 |
$ -10 |
- |
Bionovate Technologies Corp. |
$ 1 |
- |
$ 0 |
- |
Luckwel Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
Aptose Biosciences Inc. |
$ 245 |
- |
$ -32 |
- |
Cellect Biotechnology Ltd. |
$ 464 |
- |
$ 20 |
- |
Gritstone Oncology, Inc. |
$ 414 |
$ 3 |
$ -48 |
- |
Neuronetics, Inc. |
$ 83 |
$ 59 |
$ -26 |
- |
Iterum Therapeutics Plc |
$ 45 |
- |
$ -104 |
- |
Kitov Pharma Ltd. |
$ 13 |
$ 1 |
$ 6 |
- |
Immuron Ltd |
- |
$ 2 |
$ -5 |
- |
Genetic Technologies Ltd |
- |
$ 0 |
$ -6 |
- |
Bionano Genomics, Inc. |
$ 11 |
$ 5 |
$ -14 |
- |
Urovant Sciences Ltd. |
$ 370 |
- |
$ -30 |
- |
Nexien Biopharma, Inc. |
$ 2 |
- |
$ -6 |
- |
Biofrontera Ag |
$ 462 |
$ 24 |
$ -10 |
- |
Therapix Biosciences Ltd. |
- |
- |
$ 0 |
- |
Cellectis S.a. |
$ 642 |
$ 13 |
$ -88 |
- |
Replicel Life Sciences Inc. |
$ 4 |
- |
$ -2 |
- |
Apollo Endosurgery, inc. |
$ 64 |
$ 55 |
$ -46 |
- |
Medicure Inc |
- |
$ 22 |
$ 3 |
- |
Prana Biotechnology Ltd |
$ 11 |
$ 0 |
$ -8 |
- |
Dbv Technologies S.a. |
- |
- |
$ -186 |
- |
Fennec Pharmaceuticals Inc. |
$ 243 |
- |
$ -12 |
- |
Midatech Pharma Plc |
- |
$ 2 |
$ -15 |
- |
Biondvax Pharmaceuticals Ltd. |
$ 1,579 |
- |
$ -88 |
- |
Vaxart, Inc. |
$ 5 |
$ 8 |
$ -19 |
- |
Predictive Oncology Inc. |
$ 9 |
$ 1 |
$ -9 |
- |
Biotechnology & Drugs Industry |
$ 648,883 |
$ 139,770 |
$ 511 |
89,094 |
Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Biotechnology & Drugs Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Biotechnology & Drugs Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Biotechnology & Drugs Industry. |
Earnings Estimates
decrease
Pessimism dominates within Biotechnology & Drugs Industry, as most of the businesses cut their earnings guidance, staggering 66.67 % have revised down earnings outlook. Overall earnings expectations for the Biotechnology & Drugs Industry were cut by %, to the annual earnings expectation of %. |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
|
% Industry
Expected EPS Growth |
Total Ranking # Within Sector # |
|
|
% Industry
Earnings Outlook Revision |
Total Ranking # Within Sector # |
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
In the current quarter 66.67 % of companies, who have issued revenue expectation within Biotechnology & Drugs Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year. |
Sales Expectations unchanged
Among companies who provide sales guidance within Biotechnology & Drugs Industry 33.33 %, have reiterated own sales estimates for the current fiscal year. |
Sales Outlook decrease
In Biotechnology & Drugs Industry, there were no sales guidance decreases |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
% Industry
Expected Revenue Growth |
Total Ranking # Within Sector # |
|
|
% Industry
Revenue Outlook Revision |
Total Ranking # Within Sector # |
|
|
|
Cardiovascular Segment |
Revenues |
Income |
- |
- |
- |
- |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Neuroscience Segment |
Revenues |
Income |
- |
- |
- |
- |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Anti-Infective Segment |
Revenues |
Income |
14.75% |
-7.45% |
23.14% |
-12.12% |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Respiratory Segment |
Revenues |
Income |
- |
- |
- |
- |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
|
|